TRPC3 Regulates the Proliferation and Apoptosis Resistance of Triple Negative Breast Cancer Cells through the TRPC3/RASA4/MAPK Pathway

Currently, there is no effective molecular-based therapy for triple-negative breast cancer (TNBC). Canonical transient receptor potential isoform 3 (TRPC3) was previously shown to be upregulated in breast cancer biopsy tissues when compared to normal breast tissues. However, the biological role of T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Qi, Yan-Xiang, Qi, Zenghua, Tsang, Suk-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520729/
https://www.ncbi.nlm.nih.gov/pubmed/31003514
http://dx.doi.org/10.3390/cancers11040558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520729/
https://www.ncbi.nlm.nih.gov/pubmed/31003514
http://dx.doi.org/10.3390/cancers11040558

Ejemplares similares